HIGH-DOSE ORAL VITAMIN C WITH MINIMAL TOPICAL BETAMETHASONE IN THE MANAGEMENT OF MILD POMPHOLYX ECZEMA: A CASE REPORT

Authors

  • Asif Ali Department of Pathology, College of Medicine, Qassim University, Saudi Arabia

Keywords:

Pompholyx, eczema, Vitamin C, betamethasone

Abstract

Background: Pompholyx eczema presents as vesicular skin eruptions in hands and feet and follows a chronic and relapsing disease course. While topical corticosteroids are routinely used for treatment, long-term use remains a major concern. Vitamin C is known for its role in immunity and wound healing. However, it has not been widely investigated in pompholyx eczema.

Case Presentation: We report the clinical case of a 45-year-old Pakistani male with a 22-year history of mild pompholyx eczema. Eczematous flares in this patient are associated with the use of medicated soaps, dishwash detergents and dryness induced by water. Interestingly, during the COVID-19 pandemic, he began taking high-dose oral vitamin C (2000 mg/day). This coincided with a significant reduction in symptoms. The patient was inspired by this improvement and designed a self-directed observational trial in consultation with a dermatologist. He started with one self-inflicted active lesion after using dishwash detergent. He started using 2000 mg/day vitamin C for 8 days and only single nightly dose of topical 0.1% betamethasone on day 6 and 7. This led to complete resolution of the lesion on day 9 and the patient documented the healing process photographically.

Conclusion:

The adjunctive role of vitamin C has the potential to reduce corticosteroid dependence in Pompholyx eczema management. However, further clinical research is warranted to explore the clinical efficacy of vitamin C in eczema.

References

1. Guillet MH, Wierzbicka E, Guillet S, Dagregorio G, Guillet G. A 3-year causative study of pompholyx in 120 patients. Arch Dermatol. 2007;143(12):1504-8.

2. Calle Sarmiento PM, Chango Azanza JJ. Dyshidrotic Eczema: A Common Cause of Palmar Dermatitis. Cureus. 2020;12(10):e10839.

3. Nishizawa A. Dyshidrotic Eczema and Its Relationship to Metal Allergy. Curr Probl Dermatol. 2016;51:80-5.

4. Lodi A, Betti R, Chiarelli G, Urbani CE, Crosti C. Epidemiological, clinical and allergological observations on pompholyx. Contact Dermatitis. 1992;26(1):17-21.

5. YoungJin K. A Case Study of Improvement in Dyshidrotic Eczema Patients Using Cellular Correction Nutritional Therapy (OCNT). CELLMED. 2023;13(7):25-25.

6. Wollina U. Pompholyx: a review of clinical features, differential diagnosis, and management. Am J Clin Dermatol. 2010;11(5):305-14.

7. Pullar JM, Carr AC, Vissers MCM. The Roles of Vitamin C in Skin Health. Nutrients. 2017;9(8):866.

8. Gref R, Deloménie C, Maksimenko A, Gouadon E, Percoco G, Lati E, Desmaële D, Zouhiri F, Couvreur P. Vitamin C-squalene bioconjugate promotes epidermal thickening and collagen production in human skin. Sci Rep. 2020;10(1).

9. Roux A, Raison-Peyron N, Joly P, et al. Pompholyx: a review of clinical features, differential diagnosis, and management. Am J Clin Dermatol. 2010;11(4):257–264.

10. Bhanusali DG, Sperling LC. Dyshidrotic eczema: a common cause of palmar dermatitis. Int J Dermatol. 2020;59(7):778–785.

11. Carr AC, Maggini S. Vitamin C and Immune Function. Nutrients. 2017;9(11):1211.

12. Wang K, Jiang H, Li W, Qiang M, Dong T, Li H. Role of Vitamin C in Skin Diseases. Front Physiol. 2018;9:819.

13. Padayatty SJ, Levine M. Vitamin C: the known and the unknown and Goldilocks. Oral Dis. 2016;22(6):463-93.

Downloads

Published

2026-01-14

How to Cite

1.
Ali A. HIGH-DOSE ORAL VITAMIN C WITH MINIMAL TOPICAL BETAMETHASONE IN THE MANAGEMENT OF MILD POMPHOLYX ECZEMA: A CASE REPORT. J Ayub Med Coll Abbottabad [Internet]. 2026 Jan. 14 [cited 2026 Jan. 19];37(3):387-9. Available from: https://jamc.ayubmed.edu.pk/index.php/jamc/article/view/14849

Issue

Vol. 37 No. 3 (2026): JOURNAL OF AYUB MEDICAL COLLEGE ABBOTTABAD

Section

CASE REPORT

License

Copyright (c) 2026 Asif Ali

Creative Commons License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License  CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.

USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.

AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.